XODUS MEDICAL, INC.
v.
THE SOULE CO.
AI-generated. These summaries, headnotes, and key points are machine-generated and may contain errors or omissions. Always verify against the full opinion text below. Not legal advice.
The court granted the plaintiffs' motion to remove the issue of indefiniteness from claim construction briefs, deferring it to the summary judgment stage.
The parties requested a status conference to clarify whether indefiniteness should be addressed during claim construction. The court ordered briefing …
The full statement of facts, procedural history, and disposition for this case are member content.
Join FLexlaw to unlock all legal intelligence© FLexlaw, Inc. — AI-generated enrichments are proprietary. All rights reserved.
Explore caselaw by topic → Browse Indefiniteness cases and more on FLexlaw
The parties requested a telephonic status conference to clarify whether the issue of indefiniteness should be addressed during claim construction briefing. (Doc. 93). The court held a hearing on August 21, 2019 and ordered the parties to brief the issue. (Doc. 99). Both parties timely submitted briefs. (Docs. 100, 101). The standard for indefiniteness is different than the standard for claim construction. See Phillips v. AWH Corp., 415 F. 3d 1303, 1327 (Fed. Cir. 2005). Many district courts1 have recognized “the Federal Circuit’s statements that indefiniteness is intertwined with claim construction mean only that the Court must attempt to
2002 WL 1892200, at *15 (N.D. Cal. Aug. 15, 2002). This district concluded “it would be more appropriate and logical to defer the full consideration of any potential indefiniteness challenges to the summary judgment stage, after all fact and expert discovery has been completed.” Uretek Holdings, Inc. v. YD West Coast Homes, Inc., No: 8:15-cv-472-T-36JSS, 2016 WL 3021880, at *3 (M.D. Fla May 26, 2016); see also Johnson & Johnson Vision Care, Inc. v. Ciba Vision Corp., 540 F. Supp. 2d 1233, 1243
(M.D. Fla. 2008) (finding the issue of indefiniteness is not properly before the court when construing claims). Therefore, the parties are not to brief indefiniteness in their respective claim construction briefs. Briefing on the issue of indefiniteness is deferred until the summary judgment stage. After consideration, it is ORDERED that: 1. The plaintiffs’ motion to have indefiniteness removed from the claim
construction briefs (Doc. 99) is GRANTED. 2. The Supplemental Case Management Report’s claims construction briefing deadlines (Docs. 84, 88) are extended as follows: a. By October 14, 2019, the parties must file their claim construction briefs.
b. By November 18, 2019, the parties must respond to the opposing party’s claim construction brief. ORDERED in Tampa, Florida on September 10, 2019. Aranda. Saou.
AMANDA ARNOLD SANSONE
United States Magistrate Judge
Cases With Similar Vibessemantic neighbors from the corpus
Citator
Cited By
-
Xodus Med., Inc. v. The Soule Co., 2018 WL 953112 (M.D. Fla. 2019)…ace-Tech, LLC, No. 13-cv1608, 2015 WL 3756187, at *1-2 (W.D. Pa. June 11, 2015); Indus. Tech. Research Inst. v. LG Elecs. Inc., No. 13-CV-2016, 2014 WL 6907449, at *2 (S.D. Cal. Dec. 8, 2014); Takeda Pharm. Co. v. Handa Pharms., LLC, C–11–00840 JCS, 2012 WL 1243109, at *16 (N.D. Cal. Apr. 11, 2012). determine what a claim means before it can determine whether the claim is invalid for indefiniteness, and not that the Court must determine indefiniteness during the claim construction proceedings.” ASM Am., Inc.…1 / 4
-
Omnia Med., LLC v. Painteq, LLC (M.D. Fla. 2023)…28, 2011) (“Several well- settled principles [including the dispositive nature of an indefiniteness finding] . . . tend to discourage rulings on indefiniteness at the Markman stage.”); Takeda Pharm. Co. v. Handa Pharms., LLC, No. C-11-00840 JCS, 2012 WL 1243109, at *16 (N.D. Cal. Apr. 11, 2012) (“Due to the largely factual nature of [the indefiniteness] inquiry, the Court concludes that [the] question is more suitable for determination on summary judgment than at the claim construction phase of the case.”)…1 / 3
Authorities Cited
- Xodus Med., Inc. v. The Soule Co., 2018 WL 953112 (M.D. Fla. 2019)
- Johnson & Johnson Vision Care, Inc. v. Ciba Vision Corp., 540 F. Supp. 2d 1233 (M.D. Fla. 2008)